AstraZeneca in Pact With Rival to Delay a Generic Drug
April 15th, 2008 at 6:00 pm (AstraZeneca|AZN|NYSE, Drugs (Pharmaceuticals), Food and Drug Administration, Generic and Brand Name Products, India, Nexium, Ranbaxy Laboratories)
Shares in the drugmaker soared on news that it reached a deal with an Indian company, delaying the release of a generic competitor to its heartburn drug Nexium.
Zrodlo (oryginalny wpis) na http://www.nytimes.com/2008/04/16/business/16drug.html?ex=1366084800&en=bcd655782156511e&ei=5088&partner=rssnyt&emc=rss,By THE ASSOCIATED PRESS